Preference-based Health status in a German outpatient cohort with multiple sclerosis

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Reese, Jens P ^a   Wienemann, Gabriele ^a   John, Axel ^a   Linnemann, Alexandra ^a   Balzer Geldsetzer, Monika ^a   Mueller, Ulrich O ^a   Eienbröker, Christian ^a   Tackenberg, Björn ^a   Dodel, Richard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Depression; EuroQol; FAMS; Fatigue; Germany; Health status; Multiple sclerosis; Quality of life

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; EXPANDED DISABILITY SEVERITY SCALE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GERMANY; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MODIFIED FATIGUE IMPACT SCALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE; OUTPATIENT; PREDICTOR VARIABLE; PROSPECTIVE STUDY; QUESTIONNAIRE; SOCIOECONOMICS; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; FEMALE; GERMANY; HEALTH STATUS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTPATIENTS; PATIENT PREFERENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84884854924     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-162     Document Type: Article

References (42)

1. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vecsei L, Milanov I. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006, 13:700-722. 10.1111/j.1468-1331.2006.01342.x, 16834700.
2. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002, 104:182-191. 10.1016/S0303-8467(02)00036-7, 12127652.
3. WHO Atlas Multiple Sclerosis Resources in the World 2008, New York: WHO Library, WHO.
4. Gruenewald DA, Higginson IJ, Vivat B, Edmonds P, Burman RE. Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review. Mult Scler 2004, 10:690-704. 10.1191/1352458504ms1116rr, 15584496.
5. Mitchell AJ, Benito-Leon J, Gonzalez JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005, 4:556-566. 10.1016/S1474-4422(05)70166-6, 16109362.
6. Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, Weinstock-Guttman B. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005, 231:29-34. 10.1016/j.jns.2004.12.009, 15792817.
7. Rivera-Navarro J, Morales-Gonzalez JM, Benito-Leon J. Informal caregiving in multiple sclerosis patients: data from the Madrid Demyelinating Disease Group study. Disabil Rehabil 2003, 25:1057-1064. 10.1080/0963828031000137766, 12944155.
8. Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003, 74:443-446. 10.1136/jnnp.74.4.443, 1738365, 12640060.
9. Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 1998, 8:43-77. 10.1023/A:1025621700003, 9658410.
10. Ruggieri RM, Palermo R, Vitello G, Gennuso M, Settipani N, Piccoli F. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5. Acta Neurol Scand 2003, 108:323-326. 10.1034/j.1600-0404.2003.00157.x, 14616301.
11. Janssens AC, van Doorn PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003, 108:389-395. 10.1034/j.1600-0404.2003.00166.x, 14616290.
12. Landro NI, Celius EG, Sletvold H. Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS). J Neurol Sci 2004, 217:211-216. 10.1016/j.jns.2003.10.012, 14706226.
13. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM G. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005, 6(2):124-130. 10.1007/s10198-004-0264-z, 19787848.
14. Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, Chang C, Lloyd S, Steward J, Stefoski D. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996, 47:129-139. 10.1212/WNL.47.1.129, 8710066.
15. Fangerau T, Schimrigk S, Haupts M, Kaeder M, Ahle G, Brune N, Klinkenberg K, Kotterba S, Mohring M, Sindern E. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria. Acta Neurol Scand 2004, 109:385-389. 10.1111/j.1600-0404.2004.00246.x, 15147460.
16. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
17. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18(Suppl 1):S79-S83.
18. Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, Trenkwalder C, Toyka KV. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002, 8:523-526. 10.1191/1352458502ms839oa, 12474995.
19. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?. Mult Scler 2005, 11:198-202. 10.1191/1352458505ms1148oa, 15794395.
20. Beck AT, Steer RA, Brown GK. Beck Depression Inventory. 2nd edn 1996, San Antonio: TX: The Psycholigal Corporation.
21. Hautzinger M, Keller F, Kühner C. BDI-II. Beck-Depressions-Inventar. Revision 2009, Pearson Assessment: Frankfurt.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983, 33:1444. 10.1212/WNL.33.11.1444, 6685237.
23. Fischer JS, Rudick RA, Cutter GR, Reingold SC, . Force NMSCOAT The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 1999, 5:244-250. Force NMSCOAT.
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452. 10.1212/WNL.33.11.1444, 6685237.
25. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999, 5:244-250.
26. Koenig HH, Bernert S, . Angermeyer MC Health Status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 2005, 67:173-182. 10.1055/s-2005-857991, 15789280, Angermeyer MC.
27. Kobelt G, Berg J, Lindgren P, Elias WG, Flachenecker P, Freidel M, Konig N, Limmroth V, Straube E. Costs and quality of life of multiple sclerosis in Germany. Eur J Health Econ 2006, 7(Suppl 2):S34-S44.
28. Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A, Hoffmann F, Kafferlein W, Kausch U, Liedtke M, et al. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol 2009, 16:713-720. 10.1111/j.1468-1331.2009.02572.x, 19475754.
29. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001, 7:340-344.
30. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002, 205:51-58. 10.1016/S0022-510X(02)00312-X, 12409184.
31. D'Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil 2006, 28:307-314. 10.1080/09638280500191753, 16492625.
32. Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001, 104:257-261.
33. Kaminska M, Kimoff R, Benedetti A, Robinson A, Bar-Or A, Lapierre Y, Schwartzman K, Trojan D. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Multiple Sclerosis Journal 2012, 18:1159-1169. 10.1177/1352458511432328, 22183937.
34. Kaminska M, Kimoff RJ, Schwartzman K, Trojan DA. Sleep disorders and fatigue in multiple sclerosis: Evidence for association and interaction. J Neurol Sci 2011, 302:7-13. 10.1016/j.jns.2010.12.008, 21241993.
35. Veauthier C, Paul F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?. Multiple Sclerosis Journal 2012, 18:248-249. 10.1177/1352458511411229, 21652611.
36. Veauthier C, Radbruch H, Gaede G, Pfueller C, Dörr J, Bellmann-Strobl J, Wernecke K-D, Zipp F, Paul F, Sieb J. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study. Multiple Sclerosis Journal 2011, 17:613-622. 10.1177/1352458510393772, 21278050.
37. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005, 76:58-63. 10.1136/jnnp.2003.017897, 1739294, 15607996.
38. Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology 2001, 56:1324-1330. 10.1212/WNL.56.10.1324, 11376182.
39. Bock M, Brandt AU, Kuchenbecker J, Dörr J, Pfueller CF, Weinges-Evers N, Gaede G, Zimmermann H, Bellmann-Strobl J, Ohlraun S, et al. Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. Br J Ophthalmol 2012, 96:62-67. 10.1136/bjo.2010.193581, 21378002.
40. Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, et al. Ganglion cell koss in relation to visual disability in multiple sclerosis. Ophthalmology 2012, 119:1250-1257. 10.1016/j.ophtha.2011.11.032, 3631566, 22365058.
41. Mowry EM, Loguidice MJ, Daniels AB, Jacobs DA, Markowitz CE, Galetta SL, Nano-Schiavi ML, Cutter GR, Maguire MG, Balcer LJ. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 2009, 80:767-772. 10.1136/jnnp.2008.165449, 19240050.
42. Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold S. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 2008, 14:988-991. 10.1177/1352458508088916, 18505775.